Abstract

Two novel, pyridinone-based chelating ligands containing separated (O,O) and (Namino,Nhet) chelating sets (Namino = secondary amine; Nhet = pyrrole N for H(L3) (1-(3-(((1H-pyrrole-2-yl)methyl)-amino)propyl)-3-hydroxy-2-methylpyridin-4(1H)-one) or pyridine N for H(L5) (3-hydroxy-2-methyl-1-(3-((pyridin-2-ylmethyl)amino)propyl)pyridin-4(1H)-one)) were synthesized via reduction of the appropriate imines. Their proton dissociation processes were explored, and the molecular structures of two synthons were assessed by X-ray crystallography. These ambidentate chelating ligands are intended to develop Co(III)/PGM (PGM = platinum group metal) heterobimetallic multitargeted complexes with anticancer potential. To explore their metal ion binding ability, the interaction with Pd(II), [(η6-p-cym)Ru]2+ and [(η5-Cp*)Rh]2+ (p-cym = 1-methyl-4-isopropylbenzene, Cp* = pentamethyl-cyclopentadienyl anion) cations was studied in aqueous solution with the combined use of pH-potentiometry, NMR and HR ESI-MS. In general, organorhodium was found to form more labile complexes over ruthenium, while complexation of the (N,N) chelating set was slower than the processes of the pyridinone unit with (O,O) coordination. Formation of the organoruthenium complexes starts at lower pH (higher thermodynamic stabilities of the corresponding complexes) than for [(η5-Cp*)Rh]2+ but, due to the higher affinity of [η6-p-cym)Ru]2+ towards hydrolysis, the complexed ligands are capable of competing with hydroxide ion in a lesser extent than for the rhodium systems. As a result, under biologically relevant conditions, the rhodium binding effectivity of the ligands becomes comparable or even slightly higher than their effectivity towards ruthenium. Our results indicate that H(L3) is a less efficient (N,N) chelator for these metal ions than H(L5). Similarly, due to the relative effectivity of the (O,O) and (N,N) chelates at a 1:1 metal-ion-to-ligand ratio, H(L5) coordinates in a (N,N) manner to both cations in the whole pH range studied while, for H(L3), the complexation starts with (O,O) coordination. At a 2:1 metal-ion-to-ligand ratio, H(L3) cannot hinder the intensive hydrolysis of the second metal ion, although a small amount of 2:1 complex with [(η5-Cp*)Rh]2+ can also be detected.

Highlights

  • In addition to a large number of organic molecules, square planar Pt(II) complexes are widely used in the chemotherapy of various cancers [1,2,3]

  • Hypoxia present in cancer tissues is a remarkable difference from normoxic conditions in healthy, untransformed cells enabling the development of metal complexes that are selectively activated under hypoxic conditions

  • With the use of ambidentate chelating ligands, in addition to Co(III), a second metal ion with proven anticancer potential (e.g., platinum group metal (PGM) ions, such as Pt(II), half-sandwich type ruthenium(II) od rhodium(III)) can be incorporated into the molecule resulting in heterobimetallic complexes [11,12]

Read more

Summary

Introduction

In addition to a large number of organic molecules, square planar Pt(II) complexes are widely used in the chemotherapy of various cancers [1,2,3]. The properties of metal complexes can be tailored significantly by changing numerous parameters (e.g., size, charge, geometry, lipophilic/hydrophilic character, thermodynamic stability, kinetic behavior of the complexes; hard–soft character of the central metal ion and the coordinating donor atoms), all the clinically applied Pt(II)-based drugs suffer from lack of selectivity resulting in serious side effects and development of resistance during the treatment [2,3,4,5]. The results indicated that 4N and 3N coordinated mononuclear complexes were formed with the tri- and dipeptide derivatives, respectively These ligands were able to bind a metal ion excess via their free hydroxamate groups.

Synthesis of the Ligands
Solution Studies
X-ray Diffraction Analysis
Results and Discussion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call